Metamizole as the Most Consumed Analgesic in Brazil During the COVID-19 Pandemic: Why Does It Matter?

BRAZIL; ESPIRITO Santo (Brazil : State)

Background: During the COVID-19 pandemic, analgesic use increased significantly, primarily due to self-medication for symptom relief. In Brazil, metamizole (dipyrone) is widely used despite international restrictions, highlighting the importance of evaluating its consumption patterns. Objective: To assess analgesic use during the COVID-19 pandemic. Methods: This cross-sectional study was conducted via a household survey in Alegre, Espírito Santo, Brazil. Structured questionnaires were used to collect data on sociodemographic characteristics, clinical conditions, and medication use. Descriptive statistics included frequency distributions, medians, and interquartile ranges. Factors associated with analgesic use were analyzed using Poisson regression with robust variance. Results: Among 694 participants, 31.6% reported using analgesics, with metamizole being the most frequently used (87.2%), followed by acetaminophen (paracetamol) (24.7%). Analgesic use was more common among individuals with polypharmacy, lower self-reported quality of life, better self-perceived health, and recent dental appointments. Conclusions: A high prevalence of analgesic use was identified, particularly of metamizole. Given its over-the-counter availability and growing evidence of risks such as liver injury and other adverse events, ongoing monitoring is essential. These findings underscore the need for public health strategies and pharmacist involvement to promote the rational and safe use of analgesics. [ABSTRACT FROM AUTHOR]

Copyright of Pharmacoepidemiology (2813-0618) is the property of MDPI and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)